KEYNOTE-585: Disappointing results for perioperative pembrolizumab in gastric cancer Editorial

  

Author:	Ilson, D. H.
Title:	KEYNOTE-585: Disappointing results for perioperative pembrolizumab in gastric cancer
Keywords:	event free survival; overall survival; cisplatin; fluorouracil; placebo; cancer combination chemotherapy; capecitabine; cancer adjuvant therapy; progression free survival; epidermal growth factor receptor 2; editorial; docetaxel; folinic acid; adjuvant chemotherapy; microsatellite instability; stomach cancer; neoadjuvant chemotherapy; drug therapy; oxaliplatin; pyrimidine; gastric cancer; perioperative care; pathological complete response; pathologic complete response; fibroblast growth factor receptor; gimeracil plus oteracil potassium plus tegafur; capecitabine plus oxaliplatin; nivolumab; claudin; human; pembrolizumab; durvalumab; atezolizumab; toripalimab; tislelizumab
Journal Title:	Translational Gastroenterology and Hepatology
Volume:	10
ISSN:	2415-1289
Publisher:	Ame Publ Co
Date Published:	2025-01-30
Start Page:	18
Language:	English
DOI:	10.21037/tgh-24-57
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85215835223&doi=10.21037%2ftgh-24-57&partnerID=40&md5=067d926b39a64e538eb7cfadc0668cc4
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222283